StockData
Moderna, Inc. logo

Moderna, Inc.

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 5/30592% above fair value
$228.44+7.61 (+3.45%)

Close on Nov 3, 2026Market cap $91.20BP/E –Yield –

Moderna Target/actual participant enrollment in newly by Quarter

Target/actual participant enrollment in newly initiated interventional trials (participants)

QuarterlyAnnual

Moderna Target/actual participant enrollment in newly: 1,242.00 participants in Q2 2026, up 265.3% from a year earlier.

Latest, Q2 2026
1,242.00
Period ended Jun 30, 2026
Change on a year earlier
+265.3%
340.00 in Q2 2025
History
34 quarters
Since Q1 2018
Sources
1
ClinicalTrials.gov API v2 (ModernaTX, Inc.)

Where the Q2 2026 figure comes from

Source: ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗

Reported in ClinicalTrials.gov API v2 (ModernaTX, Inc.).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTarget/actual participant enrollment in newly initiated interventional trials (participants)Year on yearSource
Q2 2026Jun 30, 20261,242.00+265.3%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q1 2026Mar 31, 20264,170.00+149.7%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q4 2025Dec 31, 202571,336.00-39.7%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q3 2025Sep 30, 20251,544.00-98.1%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q2 2025Jun 30, 2025340.00-36.4%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q1 2025Mar 31, 20251,670.00+509.5%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q4 2024Dec 31, 2024118,344.00+996.7%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q3 2024Sep 30, 202480,744.00+996.9%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q2 2024Jun 30, 2024535.00-95.1%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q1 2024Mar 31, 2024274.00-98.2%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q4 2023Dec 31, 202310,791.00+626.7%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q3 2023Sep 30, 20237,361.00-68.2%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q2 2023Jun 30, 202311,005.00-13.3%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q1 2023Mar 31, 202315,096.00+316.7%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q4 2022Dec 31, 20221,485.00-96.8%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q3 2022Sep 30, 202223,150.00+2,413.6%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗

Cite this data

StockData. (2026). Moderna Target/actual participant enrollment in newly, quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/ctgov-new-enrollment

See every metric in the Moderna KPI table. Data updated Nov 3, 2026.

See a number that looks wrong?